Page 63 - Read Online

of ruffling activity and filopodial protrusions and by down RE, Bigner DD, Fontebasso A, Albrecht S, Jabado N, Lindsey JC, Bailey
regulation of stress-fibers. [82] S, Gupta N, Weiss WA, Bognár L, Klekner A, Van Meter TE, Kumabe
T, Tominaga T, Elbabaa SK, Leonard JR, Rubin JB, Liau LM, Van Meir
EG, Fouladi M, Nakamura H, Cinalli G, Garami M, Hauser P, Saad AG,
Thus, OBSC is an excellent technology to address a wide Iolascon A, Jung S, Carlotti CG, Vibhakar R, Ra YS, Robinson S, Zollo
range of topics in primary brain tumor research, ranging from M, Faria CC, Chan JA, Levy ML, Sorensen PH, Meyerson M, Pomeroy
growth- and dissemination-promoting signaling, to the intricate SL, Cho YJ, Bader GD, Tabori U, Hawkins CE, Bouffet E, Scherer SW,
interrelations between the tumor and its surrounding host tissue Rutka JT, Malkin D, Clifford SC, Jones SJ, Korbel JO, Pfister SM, Marra
to the evaluation of efficaciousness of novel targeting strategies. MA, Taylor MD. Subgroup-specific structural variation across 1,000
medulloblastoma genomes. Nat 2012;488: 49-56.
3. Northcott PA, A Korshunov, H Witt H, Hielscher T, Eberhart CG, Mack S,
FUTURE PERSPECTIVES Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor
MD Medulloblastoma comprises four distinct molecular variants. J Clin
Main emphasis for improving current in vitro technologies Oncol 2011;29:1408-14.
should be given to the cellular composition and the 4. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost
biophysical and chemical environment conditions under D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W,
Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R. Integrated
which the experiment is performed. The microenvironment genomics identifies five medulloblastoma subtypes with distinct genetic
of the in vivo location of the tumor and the composition of profiles, pathway signatures and clinicopathological features. PLoS One
the neuronal and interstitial cells resident in this location 2008;3:e3088.
should guide the choice of the components. At the single 5. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC,
cell and population levels, molecular sensors for specific cell Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD,
Curran T, Gajjar A, Gilbertson RJ. Genomics identifies medulloblastoma
functions should be used for probing tumor cell behavior subgroups that are enriched for specific genetic alterations. J Clin Oncol
and therapeutic efficacy. Finally, an increased output 2006;24:1924-31.
should be strived for to enable pharmacological and genetic 6. Wang X, Dubuc AM, Ramaswamy V, Mack S, Gendoo DM, Remke
screening approaches for drug target identification. Thus, an M, Wu X, Garzia L, Luu B, Cavalli F, Peacock J, López B, Skowron
P, Zagzag D, Lyden D, Hoffman C, Cho YJ, Eberhart C, MacDonald T,
organotypic environment, specific read-outs and the high Li XN, Van Meter T, Northcott PA, Haibe-Kains B, Hawkins C, Rutka
throughput capability will be the three pillars of future in vitro JT, Bouffet E, Pfister SM, Korshunov A, Taylor MD. Medulloblastoma
approaches. A great potential lies in organotypic slice culture, subgroups remain stable across primary and metastatic compartments.
and when this technology is combined with state-of-the-art Acta neuropathol 2015;129:449-57.
microscopy, it will allow to reveal fundamental aspects of 7. Angers-Loustau A, Hering R, Werbowetski TE, Kaplan DR, Del Maestro
RF. SRC regulates actin dynamics and invasion of malignant glial cells in
local tumor cell infiltration, the interaction of neuronal and three dimensions. Mol Cancer Res 2004;2:595-605.
brain interstitial cell populations with the tumor cells and the 8. Le PU, Angers-Loustau A, de Oliveira RM, Ajlan A, Brassard CL,
evaluation of the efficaciousness of novel treatments. Dudley A, Brent H, Siu V, Trinh G, Mölenkamp G, Wang J, Seyed Sadr
M, Bedell B, Del Maestro RF, Petrecca K. DRR drives brain cancer
Financial support and sponsorship invasion by regulating cytoskeletal-focal adhesion dynamics. Oncogene
A.N. is supported by a grant of the Werner and Hedy 9. 2010;29:4636-47.
Santhana Kumar K, Tripolitsioti D, Ma M, Grahlert J, Egli KB, Fiaschetti
Berger-Janser Foundation, M.B. by the Childhood Cancer G, Shalaby T, Grotzer MA, Baumgartner M. The Ser/Thr kinase
Research Foundation Switzerland. MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based
model of SHH medulloblastoma. SpringerPlus 2015;4:19.
Conflicts of interest 10. Rottner K, Stradal TE. Actin dynamics and turnover in cell motility. Curr
Opin Cell Biol 2011;23:569-78.
There are no conflicts of interest. 11. Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev 2009;28:5-
14.
REFERENCES 12. Nurnberg A, Kitzing T, Grosse R. Nucleating actin for invasion. Nat Rev
Cancer 2011;11:177-87.
1. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford 13. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration:
SC Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, invasion of malignant gliomas and implications for treatment. J Clin
Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM. Molecular Oncol 2003;21:1624-36.
subgroups of medulloblastoma: the current consensus. Acta neuropathol 14. Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA.
2012;123:465-72. A spatial model predicts that dispersal and cell turnover limit intratumour
2. Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz heterogeneity. Nat 2015;525:261-4.
AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison 15. Palmer TD, Ashby WJ, Lewis JD, Zijlstra A. Targeting tumor cell motility
DW, Marshall CR, Lionel AC, Mack S, Dubuc A, Yao Y, Ramaswamy V, to prevent metastasis. AdvDrug Deliv Rev 2011;63:568-81.
Luu B, Rolider A, Cavalli FM, Wang X, Remke M, Wu X, Chiu RY, Chu 16. Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma
A, Chuah E, Corbett RD, Hoad GR, Jackman SD, Li Y, Lo A, Mungall multiforme. Biochim Biophys Acta 2013;1836:236-44.
KL, Nip KM, Qian JQ, Raymond AG, Thiessen NT, Varhol RJ, Birol 17. Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D. Targeting
I, Moore RA, Mungall AJ, Holt R, Kawauchi D, Roussel MF, Kool M, tumor cell motility as a strategy against invasion and metastasis. Trends
Jones DT, Witt H, Fernandez-L A, Kenney AM, Wechsler-Reya RJ, Dirks Pharmacol Sci 2013;34:283-9.
P, Aviv T, Grajkowska WA, Perek-Polnik M, Haberler CC, Delattre O, 18. Wolf K, Friedl P. Extracellular matrix determinants of proteolytic and
Reynaud SS, Doz FF, Pernet-Fattet SS, Cho BK, Kim SK, Wang KC, non-proteolytic cell migration. Trends Cell Biol 2011;21:736-44.
Scheurlen W, Eberhart CG, Fèvre-Montange M, Jouvet A, Pollack IF, 19. Ulrich TA, Jain A, Tanner K, MacKay JL, Kumar S. Probing cellular
Fan X, Muraszko KM, Gillespie GY, Di Rocco C, Massimi L, Michiels mechanobiology in three-dimensional culture with collagen-agarose
EM, Kloosterhof NK, French PJ, Kros JM, Olson JM, Ellenbogen RG, matrices. Biomaterials 2010;31:1875-84.
Zitterbart K, Kren L, Thompson RC, Cooper MK, Lach B, McLendon 20. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J

160
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦